• OPEN AN ACCOUNT
Indian Indices
Nifty
24,631.30 11.95
(0.05%)
Sensex
80,597.66 57.75
( 0.07%)
Bank Nifty
55,341.85 160.40
( 0.29%)
Nifty IT
34,833.20 140.25
( 0.40%)
Global Indices
Nasdaq
44,972.99 40.72
(0.09%)
Dow Jones
6,471.77 -17.77
(-0.27%)
Hang Seng
43,330.92 681.66
(1.60%)
Nikkei 225
9,138.90 -38.34
(-0.42%)
Forex
USD-INR
87.57 0.06
(0.07%)
EUR-INR
102.22 -0.17
(-0.17%)
GBP-INR
118.73 0.16
(0.13%)
JPY-INR
0.60 0.00
(0.37%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
167.5
37.39
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

gtl ltd
Pro Fin Capital Services reports standalone net loss of Rs 2.45 crore in the March 2025 quarter
Jun 13,2025
Net Loss of Pro Fin Capital Services reported to Rs 2.45 crore in the quarter ended March 2025 as against net loss of Rs 3.55 crore during the previous quarter ended March 2024. Sales declined 44.86% to Rs 3.22 crore in the quarter ended March 2025 as against Rs 5.84 crore during the previous quarter ended March 2024.

For the full year,net profit reported to Rs 2.92 crore in the year ended March 2025 as against net loss of Rs 0.26 crore during the previous year ended March 2024. Sales rose 14.59% to Rs 24.97 crore in the year ended March 2025 as against Rs 21.79 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales3.225.84 -45 24.9721.79 15
OPM %-8.70-32.88 -59.1156.08 -
PBDT-3.02-4.59 34 4.390.07 6171
PBT-3.03-4.67 35 4.15-0.24 LP
NP-2.45-3.55 31 2.92-0.26 LP